Disease | retinal detachment |
Phenotype | C0042170|vogt-koyanagi-harada syndrome |
Sentences | 1 |
PubMedID- 23903795 | Conclusion: intravitreal injection of bevacizumab during the corticosteroid therapy may be a treatment option for patients with decreased visual function because of persistent serous retinal detachment associated with vogt-koyanagi-harada syndrome. |
Page: 1